Projects per year
Personal profile
Personal profile
Member, Institute for Human Infections & Immunity
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 13 Similar Profiles
Aeromonas hydrophila
Medicine & Life Sciences
Enterotoxins
Medicine & Life Sciences
Yersinia pestis
Medicine & Life Sciences
Plague
Medicine & Life Sciences
Genes
Medicine & Life Sciences
Virulence
Medicine & Life Sciences
Aeromonas
Medicine & Life Sciences
Cholera Toxin
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2011 2020
Underlying mechanisms of necrotizing fasciitis during polymicrobial infections
5/15/18 → 4/30/20
Project: Other project
FDA approved non-antibiotic drugs to combat multiple drug resistant microbes
4/5/18 → 3/31/20
Project: Other project
Host-targeted therapeutics to combat drug-resistant pathogens
1/1/18 → 12/31/19
Project: Other project
Single dose, multivalent, anthrax-plague vaccines using bacteriophage T4 nanoparticle
Catholic University of America
6/1/14 → 2/28/19
Project: Other project
Grant No. 2R44AI071634-03 "Evaluation and Production of a Multivalent Adenoviral Plague Vaccine"
8/1/12 → 6/30/16
Project: Other project
Research Output 1984 2018
- 5001 Citations
- 39 h-Index
- 186 Article
2
Citations
(Scopus)
A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague
Tao, P., Mahalingam, M., Zhu, J., Moayeri, M., Sha, J., Lawrence, W., Leppla, S. H., Chopra, A. & Rao, V. B., Sep 1 2018, In : mBio. 9, 5, e01926-18.Research output: Contribution to journal › Article
Plague Vaccine
Anthrax Vaccines
Anthrax
Bacteriophage T4
Nanoparticles
1
Citation
(Scopus)
Combating multidrug-resistant pathogens with host-directed nonantibiotic therapeutics
Andersson, J. A., Sha, J., Kirtley, M. L., Reyes, E., Fitts, E. C., Dann-Grice, S. & Chopra, A., Jan 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 1, e01943.Research output: Contribution to journal › Article
Plague
Pharmaceutical Preparations
Macrophages
Acinetobacter baumannii
Klebsiella pneumoniae
5
Citations
(Scopus)
A bivalent anthrax-plague vaccine that can protect against two Tier-1 bioterror pathogens, Bacillus anthracis and Yersinia pestis
Tao, P., Mahalingam, M., Zhu, J., Moayeri, M., Kirtley, M. L., Fitts, E. C., Andersson, J. A., Lawrence, W., Leppla, S. H., Chopra, A. & Rao, V. B., Jun 26 2017, In : Frontiers in Immunology. 8, JUN, 687.Research output: Contribution to journal › Article
Plague Vaccine
Anthrax Vaccines
Yersinia pestis
Bacillus anthracis
Anthrax
5
Citations
(Scopus)
Identification of new virulence factors and vaccine candidates for Yersinia pestis
Andersson, J. A., Sha, J., Erova, T. E., Fitts, E. C., Ponnusamy, D., Kozlova, E. V., Kirtley, M. L. & Chopra, A., Oct 17 2017, In : Frontiers in cellular and infection microbiology. 7, OCT, 448.Research output: Contribution to journal › Article
Yersinia pestis
Plague
Virulence Factors
Mutagenesis
Vaccines
3
Citations
(Scopus)
Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy
Falik Zaccai, T. C., Savitzki, D., Zivony-Elboum, Y., Vilboux, T., Fitts, E. C., Shoval, Y., Kalfon, L., Samra, N., Keren, Z., Gross, B., Chasnyk, N., Straussberg, R., Mullikin, J. C., Teer, J. K., Geiger, D., Kornitzer, D., Bitterman-Deutsch, O., Samson, A. O., Wakamiya, M., Peterson, J. & 7 others, 2017, In : Brain. 140, 2, p. 370-386 17 p.Research output: Contribution to journal › Article
Leukoencephalopathies
Dinoprostone
Cytosolic Phospholipases A2
Fibroblasts
Maintenance